PRENATAL DIAGNOSIS

BeDia Genomics is proud to announce that we are now a manufacturer. This new activity was implemented through the design and development of a fetal RHD genotyping test. Manufacturing is an integral part of our Quality Management System (QMS) and ISO 13485 certification.

Since prenatal diagnosis is a major public health issue, the first test we make available belongs to our NIMoTest® (Non Invasive Molecular Test) range. It allows the genotyping of fetal RHD in maternal blood by the real-time PCR technique. The test can be automated on most laboratory platforms.

Our R&D team is working on the extension of the NIMoTest® range in order to offer you a large panel of simple, fast and automatable tests in prenatal diagnosis.